In vivo evidence for the contribution of human histocompatibility leukocyte antigen (HLA)-DQ molecules to the development of diabetes.
about
Structure of a human insulin peptide-HLA-DQ8 complex and susceptibility to type 1 diabetesDoes narcolepsy symptom severity vary according to HLA-DQB1*0602 allele status?Induction and acceleration of insulitis/diabetes in mice with a viral mimic (polyinosinic-polycytidylic acid) and an insulin self-peptideUse of nonobese diabetic mice to understand human type 1 diabetesComplex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groupsGenetic susceptibility factors of Type 1 diabetes in Asians.DR, DQ, and you: MHC alleles and autoimmunity.Transgenic models of autoimmune disease.A pancreatic beta-cell-specific homolog of glucose-6-phosphatase emerges as a major target of cell-mediated autoimmunity in diabetesAge-dependent loss of tolerance to an immunodominant epitope of glutamic acid decarboxylase in diabetic-prone RIP-B7/DR4 mice.Humanized animal models for autoimmune diseases.The importance of the Non Obese Diabetic (NOD) mouse model in autoimmune diabetesSpontaneous myocarditis mimicking human disease occurs in the presence of an appropriate MHC and non-MHC background in transgenic mice.The regulatory role of DR4 in a spontaneous diabetes DQ8 transgenic modelSensitization to gliadin induces moderate enteropathy and insulitis in nonobese diabetic-DQ8 mice.Autoreactive human T-cell receptor initiates insulitis and impaired glucose tolerance in HLA DR4 transgenic mice.Rodent models for investigating the dysregulation of immune responses in type 1 diabetes.Association between copy number variations of HLA-DQA1 and ankylosing spondylitis in the Chinese Han population.Autoreactive T cells in a partially humanized murine model of T1D.HLA-DQ and DRB1 polymorphism and susceptibility to type 1 diabetes in Jamaica.Understanding Autoimmune Diabetes through the Prism of the Tri-Molecular Complex.The HLA-DRB, -DQB polymorphism and anti-insulin antibody response in Slovenian patients with type 1 diabetes.
P2860
Q27632133-33C6ECDA-CA48-4989-AFC9-5E3B8EF2B2AAQ33573841-F0D27E5C-2D72-4AD1-BD84-68883022A0EFQ34025430-6FA5A962-9F81-4AAC-9AC9-14E22B75D33AQ34078163-EC7DA85A-6575-49DF-B702-B7CAAD87F9B7Q34113276-0A3253AF-05D9-43B3-BBE4-8DAC6F15A816Q34176662-F8B4F8A1-4D23-4C7E-97B5-CD73E7744EF5Q34206386-DE805FBE-82A5-49D4-A933-7FDCD4FB7FBAQ34554029-348668A0-260F-41AB-A71A-12A0DFAF08A0Q35170270-C44913CB-A852-4756-A4B8-1450E4AD189FQ35748417-FE5A9B60-F993-4893-8CBD-EC19246DD872Q35754332-633CC980-67FF-4800-A493-E9CA200C5BDEQ35787117-3357ED1A-B5F8-4A00-AA7A-DA1529945AC6Q36012386-98CE13FA-07CF-4FCA-8286-3E3155D11290Q36017123-23EC537B-893D-4E5E-B714-856BDCFD32EDQ36383508-804C11AB-64D5-41FD-B832-A0861BCA96F2Q36737669-BFF1D05B-6BF2-4973-AC4D-172B4BB14E7BQ36825707-86C05D10-6518-41F3-A61E-BDD973505FD0Q37374383-7CFC97C8-4A10-45FA-8B44-9216B9958753Q40231358-077AA763-8E67-4AEB-A104-20C579B0FC2BQ46636522-EE7D7DA0-249A-4624-AC03-06D4E0138E64Q49269317-E5F5163D-FCC3-4D0D-B4AE-9D778B9C6C05Q54769617-6D215492-3A58-4C38-A39E-82E1A959BFFE
P2860
In vivo evidence for the contribution of human histocompatibility leukocyte antigen (HLA)-DQ molecules to the development of diabetes.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
In vivo evidence for the contr ...... o the development of diabetes.
@ast
In vivo evidence for the contr ...... o the development of diabetes.
@en
type
label
In vivo evidence for the contr ...... o the development of diabetes.
@ast
In vivo evidence for the contr ...... o the development of diabetes.
@en
prefLabel
In vivo evidence for the contr ...... o the development of diabetes.
@ast
In vivo evidence for the contr ...... o the development of diabetes.
@en
P2093
P2860
P356
P1476
In vivo evidence for the contr ...... o the development of diabetes.
@en
P2093
P2860
P304
P356
10.1084/JEM.191.1.97
P407
P577
2000-01-01T00:00:00Z